Vitrafy Life Sciences Ltd (ASX:VFY – Get Free Report) insider John McBain purchased 27,500 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The shares were acquired at an average price of A$1.80 ($1.15) per share, with a total value of A$49,472.50 ($31,511.15).
Vitrafy Life Sciences Stock Performance
Further Reading
- Five stocks we like better than Vitrafy Life Sciences
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- How to Calculate Stock Profit
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Vitrafy Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitrafy Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
